TREK™ 1012278-08Recalls & reported problems
Abbott Vascular Inc. · TREK™ Coronary Dilatation Catheter 4.0 mm x 8 mm / Rapid-Exchange · Class 2
All models of TREK (50)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08717648138690), received between Sep 29, 2021 and Nov 22, 2024 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Difficult to Advance” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Difficult to Advance1
- Leak/Splash1
- Material Rupture1
- Material Split, Cut or Torn1
Patient problems
- Air Embolism1
- Cardiac Arrest1
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryNov 22, 2024Leak/Splash; Material Split, Cut or Torn; Leak/Splash; Material Split, Cut or Torn
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION IN THE LEFT MAIN LEFT ANTERIOR DESCENDING (LAD) ARTERY. AFTER STENT DEPLOYMENT, THE 4X8MM TREK BALLOON DILATATION CATHETER (BDC) WAS ADVANCED TO THE TARGET LESION FOR POST DILATATION; HOWEVER, THE BALLOON FAILED TO INFLATE. THEREFORE, THE BDC WAS REMOVED FROM THE PATIENT AND AIR WAS NOTED TO BE IN THE INFLATION DEVICE THAT WAS ATTACHED TO THE BDC. THE INFLATION DEVICE WAS DISCONNECTED FROM THE BDC TO REMOVE THE AIR FROM THE INFLATION DEVICE AND THE BDC WAS ADVANCE AND ATTEMPTED TO BE INFLATED A SECOND TIME WHEN CONTRAST WAS NOTED TO SHOOT DOWN THE VESSEL AND THE BALLOON WAS THOUGHT TO HAVE BURST. THE BDC WAS REMOVED AND WAS NOTED TO BE INTACT. THE PATIENT BECAME UNSTABLE AND ARRESTED; THEREFORE, CPR WAS PERFORMED, AND THE PATIENT WAS ABLE TO BE REVIVED. HOWEVER, THE PATIENT HAD BROKEN RIBS, BUT NORMAL LEFT VENTRICULAR FUNCTION. THE PATIENT WAS MONITORED FOR A FEW DAYS PRIOR TO BEING DISCHARGED. POST PROCEDURE, THE BALLOON WAS ATTEMPTED TO BE INFLATED OUTSIDE THE PATIENT ANATOMY AND SALINE WAS NOTED TO BE LEAKING FROM A HOLE IN THE SHAFT OF THE BDC. THE ACCOUNT REPORTED THAT IT WAS CONCLUDED THAT THE RESPONSE FROM THE PATIENT
Patient problems: Air Embolism; Cardiac Arrest
MAUDE report 20760618 ↗MalfunctionSep 29, 2021Material Rupture; Difficult to Advance; Material Rupture; Difficult to Advance
IT WAS REPORTED THAT DURING A RIGHT CORONARY ARTERY (RCA) INTERVENTION A NON-ABBOTT DEVICE FRACTURED IN THE VESSEL AND THE CATHETER TIP COULD NOT BE SNARED. A TREK 4.0X8MM BALLOON DILATATION CATHETER WAS ADVANCED, BUT HAD SOME DIFFICULTY PASSING THE RETAINED CATHETER TIP IN THE RCA. ONCE AT THE DESIRED LOCATION, THE BALLOON WAS INFLATED TO 16 ATMOSPHERES AND THEN TO 14 ATMOSPHERES FOR 12 SECONDS IN THE MID RCA AT THE SITE OF THE BROKEN CATHETER TIP BEFORE THE BALLOON BURST. THE DEVICE WAS REMOVED WITHOUT ISSUE. THERE WAS NO REPORTED ADVERSE PATIENT EFFECT AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. ANOTHER BALLOON WAS USED TO CONTINUE THE PROCEDURE. NO ADDITIONAL INFORMATION REGARDING THIS ISSUE WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12550615 ↗
Other Catheters, transluminal coronary angioplasty, percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page